Glow LifeTech Corp.

Recent News

  • Glow LifeTech Reports Positive Preclinical Data on Proprietary MyCell CBD Demonstrating Superior Bioavailability and Rapid Onset Time

    Toronto, Ontario--(Newsfile Corp. - November 4, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to report positive results from a preclinical pharmacokinetic study evaluating its advanced MyCell® CBD concentrate against traditional CBD oil. Overall, MyCell® CBD formulation demonstrated fast-acting absorption in under 15 minutes and 13x greater absorption of CBD at 60 minutes, providing scientific evidence of MyCell® Technology's industry...

    2021-11-04 5:00 PM EDT
  • Glow Engages Regulatory Consultant Firms to Advance Commercialization of Artemic(TM) and Other Nutraceutical Ingredients in U.S. and Mexico

    Toronto, Ontario--(Newsfile Corp. - October 27, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech innovator producing next-generation, science-backed natural ingredients, is pleased to announce that it has engaged KGK Science (KGK) and Fryer Inc. (Fryer) as two outside regulatory consultants to support commercialization efforts for Artemic™ and other MyCell® technology ingredients in U.S. and Mexico markets. Glow has engaged the regulatory consultants to progress a U.S. and Mexico market entry...

    2021-10-27 3:00 AM EDT
  • Glow Takes Receipt of MyCell Reactor for Prototyping and Formulation for Canadian Processing; Receives CSA Standards Approval

    Toronto, Ontario--(Newsfile Corp. - October 25, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech innovator producing next-generation, science-backed natural ingredients, is pleased to announce it has received its first reactor equipment, for production of its high-performance MyCell® ingredients, and successfully received CSA standards approval.The receipt of the reactor in Canada and receiving CSA standards approval will allow Glow to develop, prototype and manufacture its industry-leading MyCell® ingredients at its recently announced...

    2021-10-25 4:03 PM EDT
  • Glow LifeTech Strengthens Management Team with Manufacturing and Product Development Leaders; Provides Management Overview

    Toronto, Ontario--(Newsfile Corp. - October 14, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to provide an update on new appointments to support the Company's advancing manufacturing and commercial initiatives including the appointment of Josh Bald, CPA as Glow's dedicated CFO. As with many industries, Glow's setup of manufacturing and production related operations have been delayed due to supply shortages stemming from the COVID-19 pandemic. The Company now anticipates that these...

    2021-10-14 3:46 PM EDT
  • Glow LifeTech Announces Upgrade to OTCQB Under Ticker 'GLWLF'

    Toronto, Ontario--(Newsfile Corp. - August 16, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to announce that after successfully completing the application process, the Company has received approval from OTC Markets Group Inc. for its common shares to begin trading on the OTCQB Market ("OTCQB") under the symbol "GLWLF". The Company's common shares will remain listed on the CSE...

    2021-08-16 8:56 PM EDT
  • Glow Acquires Strategic Equity Investment in Nova Mentis

    Toronto, Ontario--(Newsfile Corp. - August 10, 2021) - Glow LifeTech Corp. (CSE: GLOW) (FSE: 9DO) ("Glow" or the "Company"), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to announce a strategic investment into Nova Mentis1 ("Nova").The Company purchased 854,000 shares in Nova at an average cost of $0.12 CAD.Nova Mentis Life Science Corp. is a Canadian-based biotechnology company and global leader in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. Their goal is to diagnose and...

    2021-08-10 9:45 PM EDT
  • Glow LifeTech Secures Canadian Processing Facility, Begins Build-out to Produce Next-Generation Cannabis Ingredients

    Toronto, Ontario--(Newsfile Corp. - May 28, 2021) - Glow LifeTech Corp. (CSE: GLOW) (FSE: 9DO) ("Glow" or the "Company"), a biotech innovator producing next-generation, science-backed natural ingredients, is pleased to report that the Company has commenced the build-out and commissioning of licensed processing space ("Processing Space") to bring a suite of fast-acting, high-absorption, water-soluble cannabis-based ingredients to the Canadian market. The Processing Space is licensed for the processing and sale of cannabis under the Canadian Cannabis Act.Glow's MyCell® technology is...

    2021-05-28 3:00 AM EDT
  • Glow LifeTech Reports on Additional Research Results on ArtemiC and Positive Implications for COVID-19 Variants

    Toronto, Ontario--(Newsfile Corp. - May 11, 2021) - Glow LifeTech Corp. (CSE: GLOW) (FSE: 9DO) ("Glow" or the "Company"), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to report on further positive findings from the Phase II clinical and preclinical studies of ArtemiC™, evaluating its efficacy as an anti-inflammatory agent to counter increased cytokine production found in COVID-19 infections including different variants.

    2021-05-11 3:00 AM EDT